data_2gvp_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2gvp _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . 0.305 39.5 t . . . . . 0 N--CA 1.47 0.531 0 CA-C-O 115.168 -2.349 . . . . 0.0 111.283 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . 0.282 97.9 m-85 43.69 98.78 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.821 2 C-N-CA 136.359 5.863 . . . . 0.0 114.957 8.882 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.4 p 69.42 164.22 0.25 Allowed 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 127.506 2.322 . . . . 0.0 110.713 -162.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -75.49 -19.12 79.58 Favored Glycine 0 CA--C 1.532 1.096 0 N-CA-C 114.799 0.68 . . . . 0.0 114.799 -174.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 64.4 mttt -75.99 148.22 81.36 Favored Pre-proline 0 CA--C 1.551 1.002 0 CA-C-N 118.937 1.369 . . . . 0.0 113.019 178.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -76.02 -114.25 0.01 OUTLIER 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 123.351 2.7 . . . . 0.0 106.26 143.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 76.8 mt 63.04 -173.66 0.16 Allowed 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 125.176 1.391 . . . . 0.0 114.308 160.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 89.8 mt -121.51 -43.61 2.39 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 117.069 2.248 . . . . 0.0 117.069 -169.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 76.23 -17.14 4.17 Favored Glycine 0 CA--C 1.531 1.089 0 O-C-N 116.574 -3.829 . . . . 0.0 112.68 65.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -86.32 177.66 48.96 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 124.969 1.271 . . . . 0.0 110.877 162.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -80.1 146.17 17.84 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 122.387 2.058 . . . . 0.0 111.357 -178.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -107.06 165.4 11.38 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 113.649 -1.614 . . . . 0.0 108.15 155.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 9.2 m -140.99 26.03 2.07 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.693 -0.63 . . . . 0.0 112.128 -170.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 8.4 mp -83.48 134.48 34.85 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.008 1.323 . . . . 0.0 108.897 -172.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 149' ' ' ARG . 19.6 m -81.42 146.79 30.1 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 124.76 1.224 . . . . 0.0 109.779 -175.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 17.5 p -64.22 148.44 50.09 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 114.293 -1.321 . . . . 0.0 110.906 177.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -51.54 -17.85 0.95 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.1 1.36 . . . . 0.0 113.688 166.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 16.5 m -80.31 -51.43 8.9 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 127.481 2.313 . . . . 0.0 111.981 169.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 139.05 5.38 1.38 Allowed Glycine 0 N--CA 1.478 1.45 0 N-CA-C 117.374 1.71 . . . . 0.0 117.374 173.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.54 140.5 31.87 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.535 1.534 . . . . 0.0 110.238 175.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.429 HH12 ' CD ' ' A' ' 233' ' ' GLU . 62.6 ttm-85 -84.52 119.68 25.45 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.722 0.809 . . . . 0.0 112.23 -166.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.67 153.94 29.31 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -167.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 9.2 p -147.85 173.66 12.61 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 126.769 2.028 . . . . 0.0 111.672 -162.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -54.5 -31.03 55.25 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.532 1.933 . . . . 0.0 114.884 -176.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 21.5 mmtm -118.68 6.72 11.6 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 -174.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -62.0 -19.94 63.37 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 118.238 0.472 . . . . 0.0 112.223 160.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -96.98 -3.05 42.29 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.783 1.233 . . . . 0.0 114.006 178.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.2 tt -53.96 121.4 7.94 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.899 0.88 . . . . 0.0 108.911 164.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 97.01 2.72 59.28 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-O 118.634 -1.092 . . . . 0.0 115.004 -173.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -138.49 155.78 48.12 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 119.91 1.855 . . . . 0.0 109.887 169.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 52.8 m95 -84.03 154.84 23.02 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.326 -0.859 . . . . 0.0 110.202 168.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -154.67 153.04 30.68 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 115.875 1.806 . . . . 0.0 115.875 175.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 88.3 mt -107.26 102.76 12.05 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 126.732 2.013 . . . . 0.0 106.912 165.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 52.4 mt -77.12 118.3 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 169.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -115.45 122.9 47.18 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.407 1.083 . . . . 0.0 110.202 -176.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -99.75 126.23 45.77 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.175 0.99 . . . . 0.0 110.522 176.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -143.23 -168.38 12.01 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 125.333 1.444 . . . . 0.0 113.935 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -126.52 161.41 28.03 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.713 1.605 . . . . 0.0 111.395 -174.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.4 m -121.47 41.96 3.21 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.052 0.941 . . . . 0.0 111.76 172.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -135.67 -19.35 1.61 Allowed 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 115.536 1.68 . . . . 0.0 115.536 173.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 21.0 m -71.34 133.75 85.13 Favored Pre-proline 0 CA--C 1.554 1.115 0 CA-C-O 116.546 -1.692 . . . . 0.0 111.193 -172.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -57.79 -56.91 1.4 Allowed 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 124.097 3.198 . . . . 0.0 117.323 -178.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -152.63 -144.0 0.14 Allowed 'General case' 0 CA--C 1.556 1.196 1 C-N-CA 133.164 4.586 . . . . 0.0 109.192 -2.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 75.2 t -43.22 140.95 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.934 1.294 . . . . 0.0 110.547 152.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 84.7 m -44.71 134.64 4.78 Favored Pre-proline 0 CA--C 1.55 0.953 0 C-N-CA 126.342 1.857 . . . . 0.0 114.799 -165.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -61.92 -11.5 21.54 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 123.174 2.583 . . . . 0.0 112.709 171.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -45.39 -28.87 0.94 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 127.425 2.29 . . . . 0.0 114.171 158.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -76.0 -38.92 56.84 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 120.078 -1.639 . . . . 0.0 112.415 170.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -63.91 -35.52 80.93 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 121.175 -0.953 . . . . 0.0 110.641 170.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -62.36 -48.25 80.62 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.996 0.816 . . . . 0.0 110.316 171.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 13.5 mttp -57.24 -26.58 60.97 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 120.76 -1.213 . . . . 0.0 113.596 173.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -70.88 -39.85 72.59 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 119.191 0.905 . . . . 0.0 112.535 167.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 23.8 mm -63.26 -50.57 78.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-N 120.152 1.342 . . . . 0.0 109.277 177.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.547 ' CB ' ' HE3' ' A' ' 283' ' ' LYS . 26.5 mt-30 -61.35 -16.17 43.45 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 113.399 0.888 . . . . 0.0 113.399 -168.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 66.4 t -62.92 -37.95 80.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-N 119.186 0.903 . . . . 0.0 110.223 173.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 90.8 t -78.17 -35.43 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 118.837 0.744 . . . . 0.0 110.573 -178.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -58.65 -46.71 86.55 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.642 0.777 . . . . 0.0 110.987 168.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . 0.533 ' CD ' ' HZ1' ' A' ' 283' ' ' LYS . 10.0 tt0 -72.21 11.89 0.51 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.756 1.622 . . . . 0.0 114.446 177.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 24.7 mt -128.16 -61.35 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 125.823 1.649 . . . . 0.0 111.301 178.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -79.6 -33.66 41.42 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 121.335 -0.853 . . . . 0.0 112.727 -176.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.9 t -70.17 -27.44 64.53 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 121.052 -1.03 . . . . 0.0 111.045 174.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 44.5 mm -63.19 -10.06 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 O-C-N 120.73 -1.231 . . . . 0.0 111.809 168.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 77.6 m 76.36 -42.25 0.43 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 128.658 2.783 . . . . 0.0 112.222 161.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 54.7 m -62.67 -66.29 0.56 Allowed 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 128.261 2.624 . . . . 0.0 109.923 175.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 11.3 mp -59.73 151.3 63.44 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 124.959 1.304 . . . . 0.0 112.451 -170.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -64.63 157.83 53.47 Favored 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 124.325 3.35 . . . . 0.0 111.236 -178.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -79.81 139.59 37.16 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.636 0.731 . . . . 0.0 111.433 178.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 46.6 tp -131.46 104.49 7.02 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.88 1.672 . . . . 0.0 109.527 -161.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 38.6 m -73.03 119.54 76.18 Favored Pre-proline 0 N--CA 1.471 0.581 0 CA-C-O 118.978 -0.534 . . . . 0.0 110.168 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -83.48 124.27 3.58 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 121.713 1.609 . . . . 0.0 108.259 165.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 28.9 tp -122.48 94.06 4.17 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.856 1.262 . . . . 0.0 110.98 -169.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -82.69 126.99 32.98 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.734 0.814 . . . . 0.0 112.029 -175.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 97.6 mt -120.32 132.67 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 126.737 2.015 . . . . 0.0 108.643 171.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 8.2 t -94.29 117.47 30.16 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.508 -0.745 . . . . 0.0 110.183 171.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 44.9 pt -85.67 24.04 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 124.161 0.985 . . . . 0.0 112.822 -178.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -125.21 54.96 10.46 Favored Pre-proline 0 CA--C 1.556 1.203 0 C-N-CA 127.226 2.211 . . . . 0.0 111.257 -162.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -79.96 58.8 7.15 Favored 'Trans proline' 0 C--N 1.36 1.158 0 C-N-CA 124.885 3.723 . . . . 0.0 113.269 -162.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -84.56 -41.01 16.89 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.363 1.465 . . . . 0.0 111.932 175.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -169.13 -11.63 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 -164.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -67.45 155.82 38.09 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 120.476 1.489 . . . . 0.0 112.626 -173.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 53.6 m -132.45 148.26 52.39 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.692 1.597 . . . . 0.0 110.407 -172.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 20.1 tttt -42.55 -49.73 5.38 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 126.021 1.728 . . . . 0.0 113.869 177.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 25.5 mp0 -73.67 -26.28 60.66 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.656 1.182 . . . . 0.0 113.726 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -71.76 -47.08 56.06 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 120.273 1.397 . . . . 0.0 111.042 171.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 17.9 mm -48.95 -50.85 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.459 1.104 . . . . 0.0 111.442 166.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -51.93 -42.19 62.62 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 178.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -66.67 -56.06 12.35 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.075 0.55 . . . . 0.0 111.506 175.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -52.33 -40.24 61.67 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 121.208 -0.933 . . . . 0.0 112.721 176.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 13.7 t -58.72 -57.31 11.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 125.099 1.36 . . . . 0.0 111.567 176.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.49 ' HZ1' ' CD ' ' A' ' 219' ' ' GLU 0.272 0.0 OUTLIER -75.03 -20.56 59.53 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -173.615 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.49 ' CD ' ' HZ1' ' A' ' 218' ' ' LYS . 0.4 OUTLIER -61.07 -46.3 91.23 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.156 1.783 . . . . 0.0 111.921 175.064 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -78.97 -38.84 35.93 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 172.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 33.1 t -166.86 134.58 2.09 Favored Pre-proline 0 N--CA 1.472 0.644 0 CA-C-N 120.052 1.296 . . . . 0.0 113.688 170.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -71.91 -0.69 8.82 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.962 2.441 . . . . 0.0 113.848 174.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 45.1 tttt -91.67 -7.75 49.03 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 120.615 1.552 . . . . 0.0 113.595 171.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 7.4 tt -85.82 145.37 27.24 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 120.953 -1.092 . . . . 0.0 111.701 -176.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 48.4 t -107.45 136.66 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 124.839 1.256 . . . . 0.0 109.868 178.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -113.67 155.85 16.03 Favored Glycine 0 N--CA 1.47 0.937 0 C-N-CA 124.97 1.272 . . . . 0.0 113.3 177.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 1.4 mp -133.71 144.18 48.96 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 126.574 1.95 . . . . 0.0 112.473 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 1.3 m -156.2 163.84 39.1 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.894 1.678 . . . . 0.0 109.384 176.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -166.15 -175.26 36.36 Favored Glycine 0 CA--C 1.524 0.621 0 O-C-N 121.546 -0.721 . . . . 0.0 113.956 -176.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 1.6 m -61.33 149.47 38.04 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 162.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.95 -37.21 60.82 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.851 0.861 . . . . 0.0 112.03 -175.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -66.33 -29.3 69.47 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 127.133 2.173 . . . . 0.0 112.923 177.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . 0.429 ' CD ' HH12 ' A' ' 149' ' ' ARG . 40.6 mt-10 -71.56 -40.69 69.83 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 120.649 -1.282 . . . . 0.0 110.869 174.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 25.7 t -67.21 -42.62 88.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.219 1.008 . . . . 0.0 110.456 174.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -56.29 -39.7 73.11 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.115 1.366 . . . . 0.0 111.468 169.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -67.44 -54.73 17.79 Favored 'General case' 0 C--N 1.345 0.395 0 O-C-N 120.563 -1.336 . . . . 0.0 112.349 176.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 7.3 p -62.25 -32.68 55.57 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 CA-C-N 118.976 0.807 . . . . 0.0 111.904 -178.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -62.62 -47.85 81.97 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.282 0.633 . . . . 0.0 111.151 172.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 28.4 mtt180 -67.62 -56.79 8.03 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.264 1.426 . . . . 0.0 113.509 177.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -64.42 -60.87 2.64 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.44 1.096 . . . . 0.0 112.53 -172.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -68.6 -8.02 38.15 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 175.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 1.7 tmm_? 61.98 56.29 2.35 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 126.885 2.074 . . . . 0.0 111.042 167.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 4.8 p -71.7 -26.12 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 N-CA-C 114.004 1.112 . . . . 0.0 114.004 -172.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -171.83 -95.57 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 127.626 2.37 . . . . 0.0 107.345 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 60.11 28.99 18.6 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.212 1.805 . . . . 0.0 114.995 176.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 3.0 t -87.57 5.42 0.04 OUTLIER Pre-proline 0 CA--C 1.56 1.364 0 N-CA-C 118.539 2.792 . . . . 0.0 118.539 170.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -79.86 163.32 23.46 Favored 'Trans proline' 0 C--N 1.361 1.205 0 CA-C-N 124.246 2.552 . . . . 0.0 109.929 174.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -62.42 -61.12 6.89 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 128.545 2.974 . . . . 0.0 118.228 14.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . 0.313 0.1 OUTLIER 20.39 41.2 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.68 1 C-N-CA 126.981 5.121 . . . . 0.0 118.261 -152.04 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.515 ' HZ2' ' N ' ' A' ' 255' ' ' ASP . 37.5 mmtm -147.66 91.01 1.9 Allowed 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 127.207 2.203 . . . . 0.0 108.8 166.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . 0.314 3.8 m-20 80.83 -118.75 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.78 1 C-N-CA 132.918 4.487 . . . . 0.0 110.903 -3.465 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -155.02 -94.49 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 120.245 1.384 . . . . 0.0 110.022 -174.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -56.28 155.4 6.89 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.969 1.707 . . . . 0.0 114.17 -173.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.68 156.77 38.99 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 -158.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' ASP . . . . . 0.515 ' N ' ' HZ2' ' A' ' 250' ' ' LYS . 32.6 t70 151.47 98.29 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.081 1 C-N-CA 132.178 4.191 . . . . 0.0 110.049 -175.774 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 178.09 -38.35 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.129 1 C-N-CA 133.188 4.595 . . . . 0.0 112.71 -25.002 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . 0.45 HG21 ' H ' ' A' ' 259' ' ' ASP 0.256 27.9 mt 104.25 125.48 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.558 3 C-N-CA 138.161 6.584 . . . . 0.0 111.529 -14.091 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . 0.308 11.5 m 72.33 -19.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.999 2 C-N-CA 137.461 6.304 . . . . 0.0 119.035 -27.09 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . 0.45 ' H ' HG21 ' A' ' 257' ' ' ILE 0.268 3.8 t0 82.58 138.32 0.06 Allowed 'General case' 0 CA--C 1.539 0.528 1 C-N-CA 131.923 4.089 . . . . 0.0 116.726 175.763 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -82.16 -14.61 55.4 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 113.814 -1.539 . . . . 0.0 113.357 162.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 15.1 m -75.55 57.4 0.95 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 127.732 2.413 . . . . 0.0 109.38 -179.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 75.8 mt -70.04 87.64 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 125.305 1.442 . . . . 0.0 107.357 178.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 14.7 pt -99.38 134.31 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 124.17 0.988 . . . . 0.0 112.837 -172.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 48.5 ttp -111.69 107.71 16.91 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.733 1.213 . . . . 0.0 108.007 172.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -81.77 125.92 31.22 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.685 0.794 . . . . 0.0 111.248 -179.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 45.2 tp -84.27 124.29 31.07 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 166.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 42.6 mm -111.83 135.35 51.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 C-N-CA 125.093 1.357 . . . . 0.0 108.652 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -84.31 149.15 24.68 Favored Glycine 0 CA--C 1.54 1.606 0 CA-C-O 118.577 -1.124 . . . . 0.0 111.322 173.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -69.6 -8.6 24.02 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 124.457 3.438 . . . . 0.0 115.4 -168.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -78.31 -39.22 40.36 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.465 1.506 . . . . 0.0 112.245 171.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -162.77 -118.33 0.45 Allowed Glycine 0 C--N 1.337 0.628 0 C-N-CA 120.427 -0.892 . . . . 0.0 115.179 -144.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -110.69 -151.36 0.48 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.859 1.264 . . . . 0.0 111.294 -168.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -78.25 163.57 25.65 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 -171.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 1.6 tt -141.04 -43.46 0.38 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.981 1.713 . . . . 0.0 110.91 -170.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -145.15 168.12 21.13 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 127.696 2.398 . . . . 0.0 108.366 178.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -158.18 120.51 3.7 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.002 1.321 . . . . 0.0 112.288 177.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -103.24 117.68 35.06 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.733 1.213 . . . . 0.0 109.152 -177.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -107.56 123.55 7.24 Favored Glycine 0 N--CA 1.47 0.952 0 CA-C-O 118.866 -0.963 . . . . 0.0 112.7 -176.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 8.3 tp60 72.59 -58.77 0.58 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 128.336 2.654 . . . . 0.0 112.033 174.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -162.29 130.75 4.11 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.494 1.518 . . . . 0.0 110.495 174.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 6.9 mtpm? -119.55 141.17 49.48 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 146.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 66.5 mtt85 -62.22 122.28 15.21 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -173.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.547 ' HE3' ' CB ' ' A' ' 182' ' ' GLN . 7.4 tmtt? -24.66 -60.11 0.06 Allowed 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 127.58 2.352 . . . . 0.0 116.661 -166.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -66.81 -19.37 69.42 Favored Glycine 0 N--CA 1.478 1.442 0 CA-C-N 119.435 1.016 . . . . 0.0 115.085 -176.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -63.43 -29.51 70.79 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 120.978 -1.307 . . . . 0.0 111.972 170.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 80.3 mt -72.25 -39.09 63.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 O-C-N 121.505 -0.747 . . . . 0.0 109.745 176.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -62.39 -38.85 91.22 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 118.783 -0.627 . . . . 0.0 111.265 170.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -61.49 -39.83 92.36 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 119.335 0.971 . . . . 0.0 113.513 172.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.76 -57.79 11.21 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 119.396 0.998 . . . . 0.0 111.983 167.104 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 94.5 mt -67.43 -33.76 64.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 O-C-N 120.949 -1.094 . . . . 0.0 111.982 -169.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -64.83 -26.62 68.41 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.236 1.014 . . . . 0.0 112.562 172.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 89.8 m -75.88 -46.93 27.55 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.359 1.064 . . . . 0.0 110.469 173.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 33.8 m-70 -65.82 -34.6 78.53 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.206 1.003 . . . . 0.0 113.123 178.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 9.0 tmm? -69.18 -26.31 64.78 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 126.242 1.817 . . . . 0.0 112.788 172.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 48.4 ttt180 -53.92 -43.21 96.24 Favored Pre-proline 0 CA--C 1.549 0.925 0 CA-C-O 117.102 -1.427 . . . . 0.0 113.474 -175.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -85.94 -40.15 0.08 OUTLIER 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 123.241 2.627 . . . . 0.0 112.507 163.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -86.23 73.59 10.18 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.453 1.101 . . . . 0.0 111.614 -178.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 22.2 mtm105 -57.93 167.67 1.14 Allowed 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 118.669 2.84 . . . . 0.0 118.669 -153.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -67.36 -177.19 0.67 Allowed 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 129.427 3.091 . . . . 0.0 115.307 -177.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 10.8 mtpt -71.61 55.52 0.25 Allowed 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 126.264 1.826 . . . . 0.0 113.603 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . 0.273 7.5 p . . . . . 0 N--CA 1.488 1.459 1 C-N-CA 133.03 4.532 . . . . 0.0 111.574 -178.492 . . . . . . . . 2 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . 0.305 39.5 t . . . . . 0 N--CA 1.47 0.531 0 CA-C-O 115.168 -2.349 . . . . 0.0 111.283 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . 0.282 97.9 m-85 43.69 98.78 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.821 2 C-N-CA 136.359 5.863 . . . . 0.0 114.957 8.882 . . . . . . . . 3 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.4 p 69.42 164.22 0.25 Allowed 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 127.506 2.322 . . . . 0.0 110.713 -162.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -75.49 -19.12 79.58 Favored Glycine 0 CA--C 1.532 1.096 0 N-CA-C 114.799 0.68 . . . . 0.0 114.799 -174.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 64.4 mttt -75.99 148.22 81.36 Favored Pre-proline 0 CA--C 1.551 1.002 0 CA-C-N 118.937 1.369 . . . . 0.0 113.019 178.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -76.02 -114.25 0.01 OUTLIER 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 123.351 2.7 . . . . 0.0 106.26 143.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 76.8 mt 63.04 -173.66 0.16 Allowed 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 125.176 1.391 . . . . 0.0 114.308 160.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 89.8 mt -121.51 -43.61 2.39 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 117.069 2.248 . . . . 0.0 117.069 -169.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 76.23 -17.14 4.17 Favored Glycine 0 CA--C 1.531 1.089 0 O-C-N 116.574 -3.829 . . . . 0.0 112.68 65.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -86.32 177.66 48.96 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 124.969 1.271 . . . . 0.0 110.877 162.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -80.1 146.17 17.84 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 122.387 2.058 . . . . 0.0 111.357 -178.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -107.06 165.4 11.38 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 113.649 -1.614 . . . . 0.0 108.15 155.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 9.2 m -140.99 26.03 2.07 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.693 -0.63 . . . . 0.0 112.128 -170.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 8.4 mp -83.48 134.48 34.85 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.008 1.323 . . . . 0.0 108.897 -172.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 149' ' ' ARG . 19.6 m -81.42 146.79 30.1 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 124.76 1.224 . . . . 0.0 109.779 -175.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 17.5 p -64.22 148.44 50.09 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 114.293 -1.321 . . . . 0.0 110.906 177.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -51.54 -17.85 0.95 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.1 1.36 . . . . 0.0 113.688 166.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 16.5 m -80.31 -51.43 8.9 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 127.481 2.313 . . . . 0.0 111.981 169.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 139.05 5.38 1.38 Allowed Glycine 0 N--CA 1.478 1.45 0 N-CA-C 117.374 1.71 . . . . 0.0 117.374 173.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.54 140.5 31.87 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.535 1.534 . . . . 0.0 110.238 175.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.454 ' HA ' ' HA ' ' A' ' 143' ' ' THR . 62.6 ttm-85 -84.52 119.68 25.45 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.722 0.809 . . . . 0.0 112.23 -166.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.67 153.94 29.31 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -167.088 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 9.2 p -147.85 173.66 12.61 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 126.769 2.028 . . . . 0.0 111.672 -162.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -54.5 -31.03 55.25 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.532 1.933 . . . . 0.0 114.884 -176.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 21.5 mmtm -118.68 6.72 11.6 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 -174.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -62.0 -19.94 63.37 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 118.238 0.472 . . . . 0.0 112.223 160.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.438 ' HB3' HD22 ' A' ' 160' ' ' LEU . 83.8 m-85 -96.98 -3.05 42.29 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.783 1.233 . . . . 0.0 114.006 178.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.2 tt -53.96 121.4 7.94 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.899 0.88 . . . . 0.0 108.911 164.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 97.01 2.72 59.28 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-O 118.634 -1.092 . . . . 0.0 115.004 -173.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -138.49 155.78 48.12 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 119.91 1.855 . . . . 0.0 109.887 169.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 52.8 m95 -84.03 154.84 23.02 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.326 -0.859 . . . . 0.0 110.202 168.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.438 HD22 ' HB3' ' A' ' 155' ' ' TYR . 2.3 pt? -154.67 153.04 30.68 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 115.875 1.806 . . . . 0.0 115.875 175.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 88.3 mt -107.26 102.76 12.05 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 126.732 2.013 . . . . 0.0 106.912 165.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 52.4 mt -77.12 118.3 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 169.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -115.45 122.9 47.18 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.407 1.083 . . . . 0.0 110.202 -176.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -99.75 126.23 45.77 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.175 0.99 . . . . 0.0 110.522 176.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -143.23 -168.38 12.01 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 125.333 1.444 . . . . 0.0 113.935 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -126.52 161.41 28.03 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.713 1.605 . . . . 0.0 111.395 -174.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.4 m -121.47 41.96 3.21 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.052 0.941 . . . . 0.0 111.76 172.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -135.67 -19.35 1.61 Allowed 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 115.536 1.68 . . . . 0.0 115.536 173.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 21.0 m -71.34 133.75 85.13 Favored Pre-proline 0 CA--C 1.554 1.115 0 CA-C-O 116.546 -1.692 . . . . 0.0 111.193 -172.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -57.79 -56.91 1.4 Allowed 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 124.097 3.198 . . . . 0.0 117.323 -178.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -152.63 -144.0 0.14 Allowed 'General case' 0 CA--C 1.556 1.196 1 C-N-CA 133.164 4.586 . . . . 0.0 109.192 -2.299 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 75.2 t -43.22 140.95 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.934 1.294 . . . . 0.0 110.547 152.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 84.7 m -44.71 134.64 4.78 Favored Pre-proline 0 CA--C 1.55 0.953 0 C-N-CA 126.342 1.857 . . . . 0.0 114.799 -165.069 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -61.92 -11.5 21.54 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 123.174 2.583 . . . . 0.0 112.709 171.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -45.39 -28.87 0.94 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 127.425 2.29 . . . . 0.0 114.171 158.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -76.0 -38.92 56.84 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 120.078 -1.639 . . . . 0.0 112.415 170.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -63.91 -35.52 80.93 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 121.175 -0.953 . . . . 0.0 110.641 170.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -62.36 -48.25 80.62 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.996 0.816 . . . . 0.0 110.316 171.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 13.5 mttp -57.24 -26.58 60.97 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 120.76 -1.213 . . . . 0.0 113.596 173.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -70.88 -39.85 72.59 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 119.191 0.905 . . . . 0.0 112.535 167.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 23.8 mm -63.26 -50.57 78.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-N 120.152 1.342 . . . . 0.0 109.277 177.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.613 ' CB ' ' HE3' ' A' ' 283' ' ' LYS . 26.5 mt-30 -61.35 -16.17 43.45 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 113.399 0.888 . . . . 0.0 113.399 -168.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 66.4 t -62.92 -37.95 80.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-N 119.186 0.903 . . . . 0.0 110.223 173.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 90.8 t -78.17 -35.43 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 118.837 0.744 . . . . 0.0 110.573 -178.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -58.65 -46.71 86.55 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.642 0.777 . . . . 0.0 110.987 168.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -72.21 11.89 0.51 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.756 1.622 . . . . 0.0 114.446 177.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 24.7 mt -128.16 -61.35 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 125.823 1.649 . . . . 0.0 111.301 178.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -79.6 -33.66 41.42 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 121.335 -0.853 . . . . 0.0 112.727 -176.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.9 t -70.17 -27.44 64.53 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 121.052 -1.03 . . . . 0.0 111.045 174.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 44.5 mm -63.19 -10.06 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 O-C-N 120.73 -1.231 . . . . 0.0 111.809 168.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 77.6 m 76.36 -42.25 0.43 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 128.658 2.783 . . . . 0.0 112.222 161.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 54.7 m -62.67 -66.29 0.56 Allowed 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 128.261 2.624 . . . . 0.0 109.923 175.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 11.3 mp -59.73 151.3 63.44 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 124.959 1.304 . . . . 0.0 112.451 -170.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -64.63 157.83 53.47 Favored 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 124.325 3.35 . . . . 0.0 111.236 -178.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -79.81 139.59 37.16 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.636 0.731 . . . . 0.0 111.433 178.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 46.6 tp -131.46 104.49 7.02 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.88 1.672 . . . . 0.0 109.527 -161.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 38.6 m -73.03 119.54 76.18 Favored Pre-proline 0 N--CA 1.471 0.581 0 CA-C-O 118.978 -0.534 . . . . 0.0 110.168 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -83.48 124.27 3.58 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 121.713 1.609 . . . . 0.0 108.259 165.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.496 HD11 HD13 ' A' ' 227' ' ' LEU . 28.9 tp -122.48 94.06 4.17 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.856 1.262 . . . . 0.0 110.98 -169.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -82.69 126.99 32.98 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.734 0.814 . . . . 0.0 112.029 -175.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 97.6 mt -120.32 132.67 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 126.737 2.015 . . . . 0.0 108.643 171.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 8.2 t -94.29 117.47 30.16 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.508 -0.745 . . . . 0.0 110.183 171.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 44.9 pt -85.67 24.04 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 124.161 0.985 . . . . 0.0 112.822 -178.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -125.21 54.96 10.46 Favored Pre-proline 0 CA--C 1.556 1.203 0 C-N-CA 127.226 2.211 . . . . 0.0 111.257 -162.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -79.96 58.8 7.15 Favored 'Trans proline' 0 C--N 1.36 1.158 0 C-N-CA 124.885 3.723 . . . . 0.0 113.269 -162.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -84.56 -41.01 16.89 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.363 1.465 . . . . 0.0 111.932 175.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -169.13 -11.63 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 -164.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -67.45 155.82 38.09 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 120.476 1.489 . . . . 0.0 112.626 -173.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 53.6 m -132.45 148.26 52.39 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.692 1.597 . . . . 0.0 110.407 -172.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 20.1 tttt -42.55 -49.73 5.38 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 126.021 1.728 . . . . 0.0 113.869 177.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 25.5 mp0 -73.67 -26.28 60.66 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.656 1.182 . . . . 0.0 113.726 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -71.76 -47.08 56.06 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 120.273 1.397 . . . . 0.0 111.042 171.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 17.9 mm -48.95 -50.85 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.459 1.104 . . . . 0.0 111.442 166.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -51.93 -42.19 62.62 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 178.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -66.67 -56.06 12.35 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.075 0.55 . . . . 0.0 111.506 175.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -52.33 -40.24 61.67 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 121.208 -0.933 . . . . 0.0 112.721 176.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 13.7 t -58.72 -57.31 11.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 125.099 1.36 . . . . 0.0 111.567 176.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . 0.272 0.0 OUTLIER -75.03 -20.56 59.53 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -173.615 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.07 -46.3 91.23 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.156 1.783 . . . . 0.0 111.921 175.064 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -78.97 -38.84 35.93 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 172.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 33.1 t -166.86 134.58 2.09 Favored Pre-proline 0 N--CA 1.472 0.644 0 CA-C-N 120.052 1.296 . . . . 0.0 113.688 170.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -71.91 -0.69 8.82 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.962 2.441 . . . . 0.0 113.848 174.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 45.1 tttt -91.67 -7.75 49.03 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 120.615 1.552 . . . . 0.0 113.595 171.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 7.4 tt -85.82 145.37 27.24 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 120.953 -1.092 . . . . 0.0 111.701 -176.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 48.4 t -107.45 136.66 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 124.839 1.256 . . . . 0.0 109.868 178.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -113.67 155.85 16.03 Favored Glycine 0 N--CA 1.47 0.937 0 C-N-CA 124.97 1.272 . . . . 0.0 113.3 177.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.496 HD13 HD11 ' A' ' 199' ' ' LEU . 1.4 mp -133.71 144.18 48.96 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 126.574 1.95 . . . . 0.0 112.473 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 1.3 m -156.2 163.84 39.1 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.894 1.678 . . . . 0.0 109.384 176.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -166.15 -175.26 36.36 Favored Glycine 0 CA--C 1.524 0.621 0 O-C-N 121.546 -0.721 . . . . 0.0 113.956 -176.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 1.6 m -61.33 149.47 38.04 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 162.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.95 -37.21 60.82 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.851 0.861 . . . . 0.0 112.03 -175.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -66.33 -29.3 69.47 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 127.133 2.173 . . . . 0.0 112.923 177.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -71.56 -40.69 69.83 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 120.649 -1.282 . . . . 0.0 110.869 174.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 25.7 t -67.21 -42.62 88.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.219 1.008 . . . . 0.0 110.456 174.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -56.29 -39.7 73.11 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.115 1.366 . . . . 0.0 111.468 169.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -67.44 -54.73 17.79 Favored 'General case' 0 C--N 1.345 0.395 0 O-C-N 120.563 -1.336 . . . . 0.0 112.349 176.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 7.3 p -62.25 -32.68 55.57 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 CA-C-N 118.976 0.807 . . . . 0.0 111.904 -178.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -62.62 -47.85 81.97 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.282 0.633 . . . . 0.0 111.151 172.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 28.4 mtt180 -67.62 -56.79 8.03 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.264 1.426 . . . . 0.0 113.509 177.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -64.42 -60.87 2.64 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.44 1.096 . . . . 0.0 112.53 -172.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -68.6 -8.02 38.15 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 175.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 1.7 tmm_? 61.98 56.29 2.35 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 126.885 2.074 . . . . 0.0 111.042 167.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 4.8 p -71.7 -26.12 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 N-CA-C 114.004 1.112 . . . . 0.0 114.004 -172.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -171.83 -95.57 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 127.626 2.37 . . . . 0.0 107.345 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 60.11 28.99 18.6 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.212 1.805 . . . . 0.0 114.995 176.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 3.0 t -87.57 5.42 0.04 OUTLIER Pre-proline 0 CA--C 1.56 1.364 0 N-CA-C 118.539 2.792 . . . . 0.0 118.539 170.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -79.86 163.32 23.46 Favored 'Trans proline' 0 C--N 1.361 1.205 0 CA-C-N 124.246 2.552 . . . . 0.0 109.929 174.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -62.42 -61.12 6.89 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 128.545 2.974 . . . . 0.0 118.228 14.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . 0.313 0.1 OUTLIER 20.39 41.2 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.68 1 C-N-CA 126.981 5.121 . . . . 0.0 118.261 -152.04 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.4 ' HE3' ' HA ' ' A' ' 254' ' ' GLU . 37.5 mmtm -147.66 91.01 1.9 Allowed 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 127.207 2.203 . . . . 0.0 108.8 166.121 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . 0.314 3.8 m-20 80.83 -118.75 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.78 1 C-N-CA 132.918 4.487 . . . . 0.0 110.903 -3.465 . . . . . . . . 3 2 . 1 . 001 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -155.02 -94.49 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 120.245 1.384 . . . . 0.0 110.022 -174.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -56.28 155.4 6.89 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.969 1.707 . . . . 0.0 114.17 -173.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 254' ' ' GLU . . . . . 0.4 ' HA ' ' HE3' ' A' ' 250' ' ' LYS . 1.0 OUTLIER -71.68 156.77 38.99 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 -158.743 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 255' ' ' ASP . . . . . 0.413 ' HA ' ' HB2' ' A' ' 256' ' ' TYR . 32.6 t70 151.47 98.29 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.081 1 C-N-CA 132.178 4.191 . . . . 0.0 110.049 -175.774 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 256' ' ' TYR . . . . . 0.413 ' HB2' ' HA ' ' A' ' 255' ' ' ASP . 0.3 OUTLIER 178.09 -38.35 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.129 1 C-N-CA 133.188 4.595 . . . . 0.0 112.71 -25.002 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 257' ' ' ILE . . . . . 0.534 ' HA ' ' H ' ' A' ' 259' ' ' ASP 0.256 27.9 mt 104.25 125.48 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.558 3 C-N-CA 138.161 6.584 . . . . 0.0 111.529 -14.091 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 258' ' ' VAL . . . . . 0.423 HG22 ' H ' ' A' ' 257' ' ' ILE 0.308 11.5 m 72.33 -19.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.999 2 C-N-CA 137.461 6.304 . . . . 0.0 119.035 -27.09 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 259' ' ' ASP . . . . . 0.534 ' H ' ' HA ' ' A' ' 257' ' ' ILE 0.268 3.8 t0 82.58 138.32 0.06 Allowed 'General case' 0 CA--C 1.539 0.528 1 C-N-CA 131.923 4.089 . . . . 0.0 116.726 175.763 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -82.16 -14.61 55.4 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 113.814 -1.539 . . . . 0.0 113.357 162.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 15.1 m -75.55 57.4 0.95 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 127.732 2.413 . . . . 0.0 109.38 -179.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 75.8 mt -70.04 87.64 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 125.305 1.442 . . . . 0.0 107.357 178.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 14.7 pt -99.38 134.31 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 124.17 0.988 . . . . 0.0 112.837 -172.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 48.5 ttp -111.69 107.71 16.91 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.733 1.213 . . . . 0.0 108.007 172.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -81.77 125.92 31.22 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.685 0.794 . . . . 0.0 111.248 -179.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 45.2 tp -84.27 124.29 31.07 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 166.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 42.6 mm -111.83 135.35 51.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 C-N-CA 125.093 1.357 . . . . 0.0 108.652 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -84.31 149.15 24.68 Favored Glycine 0 CA--C 1.54 1.606 0 CA-C-O 118.577 -1.124 . . . . 0.0 111.322 173.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -69.6 -8.6 24.02 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 124.457 3.438 . . . . 0.0 115.4 -168.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -78.31 -39.22 40.36 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.465 1.506 . . . . 0.0 112.245 171.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -162.77 -118.33 0.45 Allowed Glycine 0 C--N 1.337 0.628 0 C-N-CA 120.427 -0.892 . . . . 0.0 115.179 -144.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -110.69 -151.36 0.48 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.859 1.264 . . . . 0.0 111.294 -168.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -78.25 163.57 25.65 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 -171.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 1.6 tt -141.04 -43.46 0.38 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.981 1.713 . . . . 0.0 110.91 -170.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -145.15 168.12 21.13 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 127.696 2.398 . . . . 0.0 108.366 178.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -158.18 120.51 3.7 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.002 1.321 . . . . 0.0 112.288 177.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -103.24 117.68 35.06 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.733 1.213 . . . . 0.0 109.152 -177.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -107.56 123.55 7.24 Favored Glycine 0 N--CA 1.47 0.952 0 CA-C-O 118.866 -0.963 . . . . 0.0 112.7 -176.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 8.3 tp60 72.59 -58.77 0.58 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 128.336 2.654 . . . . 0.0 112.033 174.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -162.29 130.75 4.11 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.494 1.518 . . . . 0.0 110.495 174.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 6.9 mtpm? -119.55 141.17 49.48 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 146.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 66.5 mtt85 -62.22 122.28 15.21 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -173.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.613 ' HE3' ' CB ' ' A' ' 182' ' ' GLN . 7.4 tmtt? -24.66 -60.11 0.06 Allowed 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 127.58 2.352 . . . . 0.0 116.661 -166.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -66.81 -19.37 69.42 Favored Glycine 0 N--CA 1.478 1.442 0 CA-C-N 119.435 1.016 . . . . 0.0 115.085 -176.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -63.43 -29.51 70.79 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 120.978 -1.307 . . . . 0.0 111.972 170.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 80.3 mt -72.25 -39.09 63.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 O-C-N 121.505 -0.747 . . . . 0.0 109.745 176.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -62.39 -38.85 91.22 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 118.783 -0.627 . . . . 0.0 111.265 170.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -61.49 -39.83 92.36 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 119.335 0.971 . . . . 0.0 113.513 172.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.76 -57.79 11.21 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 119.396 0.998 . . . . 0.0 111.983 167.104 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 94.5 mt -67.43 -33.76 64.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 O-C-N 120.949 -1.094 . . . . 0.0 111.982 -169.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -64.83 -26.62 68.41 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.236 1.014 . . . . 0.0 112.562 172.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 89.8 m -75.88 -46.93 27.55 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.359 1.064 . . . . 0.0 110.469 173.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 33.8 m-70 -65.82 -34.6 78.53 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.206 1.003 . . . . 0.0 113.123 178.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 9.0 tmm? -69.18 -26.31 64.78 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 126.242 1.817 . . . . 0.0 112.788 172.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 48.4 ttt180 -53.92 -43.21 96.24 Favored Pre-proline 0 CA--C 1.549 0.925 0 CA-C-O 117.102 -1.427 . . . . 0.0 113.474 -175.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -85.94 -40.15 0.08 OUTLIER 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 123.241 2.627 . . . . 0.0 112.507 163.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -86.23 73.59 10.18 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.453 1.101 . . . . 0.0 111.614 -178.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 22.2 mtm105 -57.93 167.67 1.14 Allowed 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 118.669 2.84 . . . . 0.0 118.669 -153.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -67.36 -177.19 0.67 Allowed 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 129.427 3.091 . . . . 0.0 115.307 -177.086 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 10.8 mtpt -71.61 55.52 0.25 Allowed 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 126.264 1.826 . . . . 0.0 113.603 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . 0.273 7.5 p . . . . . 0 N--CA 1.488 1.459 1 C-N-CA 133.03 4.532 . . . . 0.0 111.574 -178.492 . . . . . . . . 2 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . 0.305 39.5 t . . . . . 0 N--CA 1.47 0.531 0 CA-C-O 115.168 -2.349 . . . . 0.0 111.283 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . 0.282 97.9 m-85 43.69 98.78 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.821 2 C-N-CA 136.359 5.863 . . . . 0.0 114.957 8.882 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.4 p 69.42 164.22 0.25 Allowed 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 127.506 2.322 . . . . 0.0 110.713 -162.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -75.49 -19.12 79.58 Favored Glycine 0 CA--C 1.532 1.096 0 N-CA-C 114.799 0.68 . . . . 0.0 114.799 -174.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 64.4 mttt -75.99 148.22 81.36 Favored Pre-proline 0 CA--C 1.551 1.002 0 CA-C-N 118.937 1.369 . . . . 0.0 113.019 178.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -76.02 -114.25 0.01 OUTLIER 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 123.351 2.7 . . . . 0.0 106.26 143.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 76.8 mt 63.04 -173.66 0.16 Allowed 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 125.176 1.391 . . . . 0.0 114.308 160.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 89.8 mt -121.51 -43.61 2.39 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 117.069 2.248 . . . . 0.0 117.069 -169.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 76.23 -17.14 4.17 Favored Glycine 0 CA--C 1.531 1.089 0 O-C-N 116.574 -3.829 . . . . 0.0 112.68 65.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -86.32 177.66 48.96 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 124.969 1.271 . . . . 0.0 110.877 162.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -80.1 146.17 17.84 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 122.387 2.058 . . . . 0.0 111.357 -178.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -107.06 165.4 11.38 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 113.649 -1.614 . . . . 0.0 108.15 155.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 9.2 m -140.99 26.03 2.07 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.693 -0.63 . . . . 0.0 112.128 -170.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 8.4 mp -83.48 134.48 34.85 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.008 1.323 . . . . 0.0 108.897 -172.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 149' ' ' ARG . 19.6 m -81.42 146.79 30.1 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 124.76 1.224 . . . . 0.0 109.779 -175.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 17.5 p -64.22 148.44 50.09 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 114.293 -1.321 . . . . 0.0 110.906 177.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -51.54 -17.85 0.95 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.1 1.36 . . . . 0.0 113.688 166.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 16.5 m -80.31 -51.43 8.9 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 127.481 2.313 . . . . 0.0 111.981 169.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 139.05 5.38 1.38 Allowed Glycine 0 N--CA 1.478 1.45 0 N-CA-C 117.374 1.71 . . . . 0.0 117.374 173.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.54 140.5 31.87 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.535 1.534 . . . . 0.0 110.238 175.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.454 ' HA ' ' HA ' ' A' ' 143' ' ' THR . 62.6 ttm-85 -84.52 119.68 25.45 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.722 0.809 . . . . 0.0 112.23 -166.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.67 153.94 29.31 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -167.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 9.2 p -147.85 173.66 12.61 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 126.769 2.028 . . . . 0.0 111.672 -162.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -54.5 -31.03 55.25 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.532 1.933 . . . . 0.0 114.884 -176.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 21.5 mmtm -118.68 6.72 11.6 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 -174.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -62.0 -19.94 63.37 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 118.238 0.472 . . . . 0.0 112.223 160.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.438 ' HB3' HD22 ' A' ' 160' ' ' LEU . 83.8 m-85 -96.98 -3.05 42.29 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.783 1.233 . . . . 0.0 114.006 178.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.2 tt -53.96 121.4 7.94 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.899 0.88 . . . . 0.0 108.911 164.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 97.01 2.72 59.28 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-O 118.634 -1.092 . . . . 0.0 115.004 -173.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -138.49 155.78 48.12 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 119.91 1.855 . . . . 0.0 109.887 169.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 52.8 m95 -84.03 154.84 23.02 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.326 -0.859 . . . . 0.0 110.202 168.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.438 HD22 ' HB3' ' A' ' 155' ' ' TYR . 2.3 pt? -154.67 153.04 30.68 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 115.875 1.806 . . . . 0.0 115.875 175.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 88.3 mt -107.26 102.76 12.05 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 126.732 2.013 . . . . 0.0 106.912 165.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 52.4 mt -77.12 118.3 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 169.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -115.45 122.9 47.18 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.407 1.083 . . . . 0.0 110.202 -176.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -99.75 126.23 45.77 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.175 0.99 . . . . 0.0 110.522 176.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -143.23 -168.38 12.01 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 125.333 1.444 . . . . 0.0 113.935 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -126.52 161.41 28.03 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.713 1.605 . . . . 0.0 111.395 -174.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.4 m -121.47 41.96 3.21 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.052 0.941 . . . . 0.0 111.76 172.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -135.67 -19.35 1.61 Allowed 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 115.536 1.68 . . . . 0.0 115.536 173.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 21.0 m -71.34 133.75 85.13 Favored Pre-proline 0 CA--C 1.554 1.115 0 CA-C-O 116.546 -1.692 . . . . 0.0 111.193 -172.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -57.79 -56.91 1.4 Allowed 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 124.097 3.198 . . . . 0.0 117.323 -178.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -152.63 -144.0 0.14 Allowed 'General case' 0 CA--C 1.556 1.196 1 C-N-CA 133.164 4.586 . . . . 0.0 109.192 -2.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 75.2 t -43.22 140.95 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.934 1.294 . . . . 0.0 110.547 152.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 84.7 m -44.71 134.64 4.78 Favored Pre-proline 0 CA--C 1.55 0.953 0 C-N-CA 126.342 1.857 . . . . 0.0 114.799 -165.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -61.92 -11.5 21.54 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 123.174 2.583 . . . . 0.0 112.709 171.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -45.39 -28.87 0.94 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 127.425 2.29 . . . . 0.0 114.171 158.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -76.0 -38.92 56.84 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 120.078 -1.639 . . . . 0.0 112.415 170.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -63.91 -35.52 80.93 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 121.175 -0.953 . . . . 0.0 110.641 170.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -62.36 -48.25 80.62 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.996 0.816 . . . . 0.0 110.316 171.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 13.5 mttp -57.24 -26.58 60.97 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 120.76 -1.213 . . . . 0.0 113.596 173.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -70.88 -39.85 72.59 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 119.191 0.905 . . . . 0.0 112.535 167.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 23.8 mm -63.26 -50.57 78.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-N 120.152 1.342 . . . . 0.0 109.277 177.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.613 ' CB ' ' HE3' ' A' ' 283' ' ' LYS . 26.5 mt-30 -61.35 -16.17 43.45 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 113.399 0.888 . . . . 0.0 113.399 -168.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 66.4 t -62.92 -37.95 80.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-N 119.186 0.903 . . . . 0.0 110.223 173.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 90.8 t -78.17 -35.43 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 118.837 0.744 . . . . 0.0 110.573 -178.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -58.65 -46.71 86.55 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.642 0.777 . . . . 0.0 110.987 168.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -72.21 11.89 0.51 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.756 1.622 . . . . 0.0 114.446 177.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 24.7 mt -128.16 -61.35 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 125.823 1.649 . . . . 0.0 111.301 178.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -79.6 -33.66 41.42 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 121.335 -0.853 . . . . 0.0 112.727 -176.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.9 t -70.17 -27.44 64.53 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 121.052 -1.03 . . . . 0.0 111.045 174.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 44.5 mm -63.19 -10.06 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 O-C-N 120.73 -1.231 . . . . 0.0 111.809 168.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 77.6 m 76.36 -42.25 0.43 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 128.658 2.783 . . . . 0.0 112.222 161.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 54.7 m -62.67 -66.29 0.56 Allowed 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 128.261 2.624 . . . . 0.0 109.923 175.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 11.3 mp -59.73 151.3 63.44 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 124.959 1.304 . . . . 0.0 112.451 -170.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -64.63 157.83 53.47 Favored 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 124.325 3.35 . . . . 0.0 111.236 -178.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -79.81 139.59 37.16 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.636 0.731 . . . . 0.0 111.433 178.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 46.6 tp -131.46 104.49 7.02 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.88 1.672 . . . . 0.0 109.527 -161.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 38.6 m -73.03 119.54 76.18 Favored Pre-proline 0 N--CA 1.471 0.581 0 CA-C-O 118.978 -0.534 . . . . 0.0 110.168 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -83.48 124.27 3.58 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 121.713 1.609 . . . . 0.0 108.259 165.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.496 HD11 HD13 ' A' ' 227' ' ' LEU . 28.9 tp -122.48 94.06 4.17 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.856 1.262 . . . . 0.0 110.98 -169.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -82.69 126.99 32.98 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.734 0.814 . . . . 0.0 112.029 -175.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 97.6 mt -120.32 132.67 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 126.737 2.015 . . . . 0.0 108.643 171.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 8.2 t -94.29 117.47 30.16 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.508 -0.745 . . . . 0.0 110.183 171.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 44.9 pt -85.67 24.04 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 124.161 0.985 . . . . 0.0 112.822 -178.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -125.21 54.96 10.46 Favored Pre-proline 0 CA--C 1.556 1.203 0 C-N-CA 127.226 2.211 . . . . 0.0 111.257 -162.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -79.96 58.8 7.15 Favored 'Trans proline' 0 C--N 1.36 1.158 0 C-N-CA 124.885 3.723 . . . . 0.0 113.269 -162.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -84.56 -41.01 16.89 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.363 1.465 . . . . 0.0 111.932 175.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -169.13 -11.63 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 -164.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -67.45 155.82 38.09 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 120.476 1.489 . . . . 0.0 112.626 -173.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 53.6 m -132.45 148.26 52.39 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.692 1.597 . . . . 0.0 110.407 -172.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 20.1 tttt -42.55 -49.73 5.38 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 126.021 1.728 . . . . 0.0 113.869 177.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 25.5 mp0 -73.67 -26.28 60.66 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.656 1.182 . . . . 0.0 113.726 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -71.76 -47.08 56.06 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 120.273 1.397 . . . . 0.0 111.042 171.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 17.9 mm -48.95 -50.85 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.459 1.104 . . . . 0.0 111.442 166.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -51.93 -42.19 62.62 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 178.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -66.67 -56.06 12.35 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.075 0.55 . . . . 0.0 111.506 175.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -52.33 -40.24 61.67 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 121.208 -0.933 . . . . 0.0 112.721 176.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 13.7 t -58.72 -57.31 11.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 125.099 1.36 . . . . 0.0 111.567 176.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . 0.272 0.0 OUTLIER -75.03 -20.56 59.53 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -173.615 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.07 -46.3 91.23 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.156 1.783 . . . . 0.0 111.921 175.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -78.97 -38.84 35.93 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 172.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 33.1 t -166.86 134.58 2.09 Favored Pre-proline 0 N--CA 1.472 0.644 0 CA-C-N 120.052 1.296 . . . . 0.0 113.688 170.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -71.91 -0.69 8.82 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.962 2.441 . . . . 0.0 113.848 174.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 45.1 tttt -91.67 -7.75 49.03 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 120.615 1.552 . . . . 0.0 113.595 171.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 7.4 tt -85.82 145.37 27.24 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 120.953 -1.092 . . . . 0.0 111.701 -176.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 48.4 t -107.45 136.66 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 124.839 1.256 . . . . 0.0 109.868 178.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -113.67 155.85 16.03 Favored Glycine 0 N--CA 1.47 0.937 0 C-N-CA 124.97 1.272 . . . . 0.0 113.3 177.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.496 HD13 HD11 ' A' ' 199' ' ' LEU . 1.4 mp -133.71 144.18 48.96 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 126.574 1.95 . . . . 0.0 112.473 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 1.3 m -156.2 163.84 39.1 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.894 1.678 . . . . 0.0 109.384 176.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -166.15 -175.26 36.36 Favored Glycine 0 CA--C 1.524 0.621 0 O-C-N 121.546 -0.721 . . . . 0.0 113.956 -176.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 1.6 m -61.33 149.47 38.04 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 162.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.95 -37.21 60.82 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.851 0.861 . . . . 0.0 112.03 -175.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -66.33 -29.3 69.47 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 127.133 2.173 . . . . 0.0 112.923 177.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -71.56 -40.69 69.83 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 120.649 -1.282 . . . . 0.0 110.869 174.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 25.7 t -67.21 -42.62 88.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.219 1.008 . . . . 0.0 110.456 174.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -56.29 -39.7 73.11 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.115 1.366 . . . . 0.0 111.468 169.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -67.44 -54.73 17.79 Favored 'General case' 0 C--N 1.345 0.395 0 O-C-N 120.563 -1.336 . . . . 0.0 112.349 176.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 7.3 p -62.25 -32.68 55.57 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 CA-C-N 118.976 0.807 . . . . 0.0 111.904 -178.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -62.62 -47.85 81.97 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.282 0.633 . . . . 0.0 111.151 172.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 28.4 mtt180 -67.62 -56.79 8.03 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.264 1.426 . . . . 0.0 113.509 177.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -64.42 -60.87 2.64 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.44 1.096 . . . . 0.0 112.53 -172.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -68.6 -8.02 38.15 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 175.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 1.7 tmm_? 61.98 56.29 2.35 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 126.885 2.074 . . . . 0.0 111.042 167.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 4.8 p -71.7 -26.12 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 N-CA-C 114.004 1.112 . . . . 0.0 114.004 -172.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -171.83 -95.57 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 127.626 2.37 . . . . 0.0 107.345 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 60.11 28.99 18.6 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.212 1.805 . . . . 0.0 114.995 176.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 3.0 t -87.57 5.42 0.04 OUTLIER Pre-proline 0 CA--C 1.56 1.364 0 N-CA-C 118.539 2.792 . . . . 0.0 118.539 170.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -79.86 163.32 23.46 Favored 'Trans proline' 0 C--N 1.361 1.205 0 CA-C-N 124.246 2.552 . . . . 0.0 109.929 174.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -62.42 -61.12 6.89 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 128.545 2.974 . . . . 0.0 118.228 14.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . 0.313 0.1 OUTLIER 20.39 41.2 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.68 1 C-N-CA 126.981 5.121 . . . . 0.0 118.261 -152.04 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.4 ' HE3' ' HA ' ' A' ' 254' ' ' GLU . 37.5 mmtm -147.66 91.01 1.9 Allowed 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 127.207 2.203 . . . . 0.0 108.8 166.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . 0.314 3.8 m-20 80.83 -118.75 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.78 1 C-N-CA 132.918 4.487 . . . . 0.0 110.903 -3.465 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -155.02 -94.49 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 120.245 1.384 . . . . 0.0 110.022 -174.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -56.28 155.4 6.89 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.969 1.707 . . . . 0.0 114.17 -173.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . 0.4 ' HA ' ' HE3' ' A' ' 250' ' ' LYS . 1.0 OUTLIER -71.68 156.77 38.99 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 -158.743 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' ASP . . . . . 0.413 ' HA ' ' HB2' ' A' ' 256' ' ' TYR . 32.6 t70 151.47 98.29 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.081 1 C-N-CA 132.178 4.191 . . . . 0.0 110.049 -175.774 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' TYR . . . . . 0.413 ' HB2' ' HA ' ' A' ' 255' ' ' ASP . 0.3 OUTLIER 178.09 -38.35 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.129 1 C-N-CA 133.188 4.595 . . . . 0.0 112.71 -25.002 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . 0.534 ' HA ' ' H ' ' A' ' 259' ' ' ASP 0.256 27.9 mt 104.25 125.48 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.558 3 C-N-CA 138.161 6.584 . . . . 0.0 111.529 -14.091 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . 0.423 HG22 ' H ' ' A' ' 257' ' ' ILE 0.308 11.5 m 72.33 -19.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.999 2 C-N-CA 137.461 6.304 . . . . 0.0 119.035 -27.09 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . 0.534 ' H ' ' HA ' ' A' ' 257' ' ' ILE 0.268 3.8 t0 82.58 138.32 0.06 Allowed 'General case' 0 CA--C 1.539 0.528 1 C-N-CA 131.923 4.089 . . . . 0.0 116.726 175.763 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -82.16 -14.61 55.4 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 113.814 -1.539 . . . . 0.0 113.357 162.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 15.1 m -75.55 57.4 0.95 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 127.732 2.413 . . . . 0.0 109.38 -179.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 75.8 mt -70.04 87.64 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 125.305 1.442 . . . . 0.0 107.357 178.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 14.7 pt -99.38 134.31 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 124.17 0.988 . . . . 0.0 112.837 -172.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 48.5 ttp -111.69 107.71 16.91 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.733 1.213 . . . . 0.0 108.007 172.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -81.77 125.92 31.22 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.685 0.794 . . . . 0.0 111.248 -179.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 45.2 tp -84.27 124.29 31.07 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 166.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 42.6 mm -111.83 135.35 51.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 C-N-CA 125.093 1.357 . . . . 0.0 108.652 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -84.31 149.15 24.68 Favored Glycine 0 CA--C 1.54 1.606 0 CA-C-O 118.577 -1.124 . . . . 0.0 111.322 173.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -69.6 -8.6 24.02 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 124.457 3.438 . . . . 0.0 115.4 -168.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -78.31 -39.22 40.36 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.465 1.506 . . . . 0.0 112.245 171.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -162.77 -118.33 0.45 Allowed Glycine 0 C--N 1.337 0.628 0 C-N-CA 120.427 -0.892 . . . . 0.0 115.179 -144.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -110.69 -151.36 0.48 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.859 1.264 . . . . 0.0 111.294 -168.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -78.25 163.57 25.65 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 -171.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 1.6 tt -141.04 -43.46 0.38 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.981 1.713 . . . . 0.0 110.91 -170.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -145.15 168.12 21.13 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 127.696 2.398 . . . . 0.0 108.366 178.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -158.18 120.51 3.7 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.002 1.321 . . . . 0.0 112.288 177.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -103.24 117.68 35.06 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.733 1.213 . . . . 0.0 109.152 -177.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -107.56 123.55 7.24 Favored Glycine 0 N--CA 1.47 0.952 0 CA-C-O 118.866 -0.963 . . . . 0.0 112.7 -176.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 8.3 tp60 72.59 -58.77 0.58 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 128.336 2.654 . . . . 0.0 112.033 174.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -162.29 130.75 4.11 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.494 1.518 . . . . 0.0 110.495 174.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 6.9 mtpm? -119.55 141.17 49.48 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 146.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 66.5 mtt85 -62.22 122.28 15.21 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -173.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.613 ' HE3' ' CB ' ' A' ' 182' ' ' GLN . 7.4 tmtt? -24.66 -60.11 0.06 Allowed 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 127.58 2.352 . . . . 0.0 116.661 -166.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -66.81 -19.37 69.42 Favored Glycine 0 N--CA 1.478 1.442 0 CA-C-N 119.435 1.016 . . . . 0.0 115.085 -176.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -63.43 -29.51 70.79 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 120.978 -1.307 . . . . 0.0 111.972 170.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 80.3 mt -72.25 -39.09 63.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 O-C-N 121.505 -0.747 . . . . 0.0 109.745 176.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -62.39 -38.85 91.22 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 118.783 -0.627 . . . . 0.0 111.265 170.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -61.49 -39.83 92.36 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 119.335 0.971 . . . . 0.0 113.513 172.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.76 -57.79 11.21 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 119.396 0.998 . . . . 0.0 111.983 167.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 94.5 mt -67.43 -33.76 64.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 O-C-N 120.949 -1.094 . . . . 0.0 111.982 -169.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -64.83 -26.62 68.41 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.236 1.014 . . . . 0.0 112.562 172.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 89.8 m -75.88 -46.93 27.55 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.359 1.064 . . . . 0.0 110.469 173.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 33.8 m-70 -65.82 -34.6 78.53 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.206 1.003 . . . . 0.0 113.123 178.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 9.0 tmm? -69.18 -26.31 64.78 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 126.242 1.817 . . . . 0.0 112.788 172.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 48.4 ttt180 -53.92 -43.21 96.24 Favored Pre-proline 0 CA--C 1.549 0.925 0 CA-C-O 117.102 -1.427 . . . . 0.0 113.474 -175.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -85.94 -40.15 0.08 OUTLIER 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 123.241 2.627 . . . . 0.0 112.507 163.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -86.23 73.59 10.18 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.453 1.101 . . . . 0.0 111.614 -178.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 22.2 mtm105 -57.93 167.67 1.14 Allowed 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 118.669 2.84 . . . . 0.0 118.669 -153.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -67.36 -177.19 0.67 Allowed 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 129.427 3.091 . . . . 0.0 115.307 -177.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 10.8 mtpt -71.61 55.52 0.25 Allowed 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 126.264 1.826 . . . . 0.0 113.603 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . 0.273 7.5 p . . . . . 0 N--CA 1.488 1.459 1 C-N-CA 133.03 4.532 . . . . 0.0 111.574 -178.492 . . . . . . . . 2 1 . 1 stop_ save_